Trial
NCT05897372
Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Iain Bressendorff
Collaborators
—
Condition
Diabetic Kidney Disease
Intervention
ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
Why stopped
Slow recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-25